Results 11 to 20 of about 1,441,839 (169)

Prenatal Diagnosis and Pregnancy Outcome Analysis of High-risk Fetuses Suggested by Noninvasive Prenatal Screening [PDF]

open access: yesZhongguo quanke yixue, 2022
Background Noninvasive prenatal screening is more effective in screening for fetal aneuploidy than does traditional serological screening. We attempted to analyze the real-world data about the positive predictive value (PPV) for chromosome aneuploidy ...
Yan LUO, Bingyi ZHAO, Yanmei SUN, Haishen TIAN, Yali LI, Yanshang ZHANG, Jian GAO, Zhiqiang CUI
doaj   +3 more sources

Noninvasive screening tools for Down syndrome: a review

open access: yesInternational Journal of Women's Health, 2013
Meagan Smith, Jeannie Visootsak Emory University, Department of Human Genetics, Atlanta, GA, USA Abstract: Down syndrome is the leading cause of prenatal chromosome abnormalities, accounting for 53% of all reported chromosome conditions.
Smith M, Visootsak J
doaj   +1 more source

From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2013
Down syndrome is the most common autosomal chromosome aneuploidy. The prenatal Down syndrome screening protocol has been known in Taiwan for the past 20 years.
S.W. Steven Shaw   +2 more
doaj   +2 more sources

Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants. [PDF]

open access: yesPrenat Diagn, 2023
OBJECTIVES: Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries.
Jeppesen LD   +9 more
europepmc   +2 more sources

Understandings of Down's syndrome and their place in the prenatal testing context [PDF]

open access: yes, 2003
INTRODUCTION: There is a growing consensus that decisions about prenatal testing should a) be informed, and b) reflect the individual's attitudes and values.
Bryant, Louise Dorothy
core   +6 more sources

Prenatal identification of an inverted duplicated 13q marker chromosome with a neocentromere

open access: yesMolecular Cytogenetics, 2023
In this case report, we describe a rare prenatal finding of a small marker chromosome. This marker chromosome corresponds to an inverted duplication of the 13q region 13q31.1q34 (or 13q31.1 → qter) with a neocentromere, detected during genetic analysis ...
Liselot van der Laan   +4 more
doaj   +1 more source

Diagnostic value of NIPT assay for fetal aneuploidy screening in pregnant women with moderate risk of trisomy in first stage screening [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2022
Introduction: Aneuploidies are of the most important fetal abnormalities. Diagnostic value and efficacy of NIPT assay in the groups with abnormal results for first trimester combined screening test is not well defined. Therefore, this study was performed
Fatemeh Lalooha   +5 more
doaj   +1 more source

Non-invasive prenatal screening tests – update 2022

open access: yesJournal of Laboratory Medicine, 2022
Since 2012, non-invasive prenatal testing (NIPT) using cell-free DNA from maternal plasma is applied all over the world as highly efficient first-line or contingent screening approach for trisomy 13, 18 and 21.
Kypri Elena   +5 more
doaj   +1 more source

Increasing prenatal diagnosis of chimeras with the use of noninvasive prenatal screening: Report of two cases

open access: yes, 2021
Bulleted Statements: What's already known about this topic? The incidence of discordant fetal sex was estimated to be 1 in 1500-2000. Comprehensive evaluation is required to investigate the underlying cause. What does this study add?
Ma, TWL   +7 more
core   +1 more source

Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology

open access: yesCurrent Issues in Molecular Biology, 2021
Background: Rolling-circle replication (RCR) is a novel technology that has not been applied to cell-free DNA (cfDNA) testing until recently. Given the cost and simplicity advantages of this technology compared to other platforms currently used in cfDNA ...
Uzay Gormus   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy